Related Experiment Videos
Groin lymphatic complications after arterial reconstruction
S H Tyndall1, A D Shepard, J M Wilczewski
1Department of Surgery, Henry Ford Hospital, Detroit, MI 48202.
Journal of Vascular Surgery
|May 1, 1994
Summary
Groin lymphatic complications (GLC) after femoral artery surgery are uncommon but can be serious. Early reoperation for lymphocutaneous fistulas speeds recovery and prevents infection, while lymphocele treatment should be individualized.
Area of Science:
- Vascular Surgery
- Surgical Complications
- Lymphatic System
Background:
- Groin lymphatic complications (GLC) are a recognized challenge following femoral artery reconstructive operations.
- Understanding the incidence and risk factors for GLC is crucial for optimizing patient outcomes.
Purpose of the Study:
- To define the risks associated with groin lymphatic complications (GLC) after femoral artery reconstructive operations.
- To determine the optimal management strategies for GLC, including lymphocutaneous fistulas (LF) and lymphoceles.
Main Methods:
- Retrospective review of a 15-year vascular surgery registry.
- Analysis of 2679 arterial operations with groin incisions, identifying 41 cases of GLC (28 LF, 13 lymphoceles).
Main Results:
- The overall incidence of GLC was 1.5% per patient. High-risk procedures included aortobifemoral bypass for aneurysm in previously operated groins (8.1%) and isolated femoral procedures in previously operated groins (5.3%).
- Nonoperative management (bedrest, antibiotics, wound care) was used in 71% of cases. Operative therapy was used in 29% of cases.
- Early reoperation for LF significantly reduced healing time (9 vs. 24 days) and prevented infectious complications, including graft infections. Operative management of lymphoceles did not improve outcomes.
Conclusions:
- Groin lymphatic complications (GLC) are a significant concern after femoral artery reconstruction.
- Early surgical reintervention for lymphocutaneous fistulas (LF) is recommended to expedite healing and reduce infectious risks.
- Management of lymphoceles should be tailored to the individual patient, as neither operative nor nonoperative approaches demonstrate clear superiority.